Updated Jul 16, 2026
McKee Amy E has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $100K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 15.3K | $0.00 | |
| 2026-06-02 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 631 | $8.91 | $6K |
| 2026-05-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | S — Open-market sale | 11.2K | $8.97 | $100K |
| 2026-03-03 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 642 | $8.75 | $6K |
| 2025-08-29 | BCRX | BIOCRYST PHARMACEUTICALS INC | A — Grant or award | 676 | $8.31 | $6K |
McKee Amy E is a corporate insider — currently tracked as Director of BIOCRYST PHARMACEUTICALS INC (BCRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($100K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McKee Amy E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.